Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (231-240 of 773) with videos related to

Pageof 78
Sort By:
Clinical Lymphoma & Myeloma|April 14, 2009
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemiaRobert A Kyle, Joanne Benson, Dirk Larson, et al.
Cancer|October 14, 2004
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decadesRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Blood Cancer Journal|November 5, 2023
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physiciansRahul Banerjee, Bo Wang, Larry D Anderson, et al.
American Journal of Hematology|November 19, 2016
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitorsHayan Jouni, Mary C Aubry, Martha Q Lacy, et al.
Blood Cancer Journal|February 10, 2021
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Li Pang, S Vincent Rajkumar, Prashant Kapoor, et al.
American Journal of Hematology|September 16, 2010
IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemiaSteven R Schuster, Sundararajan Vincent Rajkumar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2017
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the LiteratureMichael P Rassner, Maximilian Seidl, Ulrich Salzer, et al.
Blood|May 16, 2002
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemiaRuben A Mesa, Curtis A Hanson, Chin-Yang Li, et al.
Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Pageof 78

Showing results (231-240 of 773) with videos related to

Sort By:
Pageof 78
Clinical Lymphoma & Myeloma|April 14, 2009
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemiaRobert A Kyle, Joanne Benson, Dirk Larson, et al.
Cancer|October 14, 2004
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decadesRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Blood Cancer Journal|November 5, 2023
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physiciansRahul Banerjee, Bo Wang, Larry D Anderson, et al.
American Journal of Hematology|November 19, 2016
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitorsHayan Jouni, Mary C Aubry, Martha Q Lacy, et al.
Blood Cancer Journal|February 10, 2021
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Li Pang, S Vincent Rajkumar, Prashant Kapoor, et al.
American Journal of Hematology|September 16, 2010
IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemiaSteven R Schuster, Sundararajan Vincent Rajkumar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2017
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the LiteratureMichael P Rassner, Maximilian Seidl, Ulrich Salzer, et al.
Blood|May 16, 2002
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemiaRuben A Mesa, Curtis A Hanson, Chin-Yang Li, et al.
Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
Pageof 78